Literature DB >> 8171099

Physical disablement concepts for physical therapy research and practice.

A M Jette1.   

Abstract

Disability, one of modern society's greatest public health problems, affects individuals, families, and society. Understanding the complex process of disablement, therefore, is critical given the current and projected increases in disability. Terminology in the field of disablement continues to breed confusion and controversy across and within disciplines. This article discusses some of the major models that have been developed to guide physical therapy researchers and clinicians in their thinking about disablement. Emphasis is on physical disablement because of its central role in physical therapy research and practice. Detailed descriptions are provided for two disablement formulations. One was developed in the 1960s by sociologist Saad Nagi. The other is the International Classification of Impairments, Disabilities, and Handicaps, developed for the World Health Organization. Both can serve as the basic conceptual architecture for disablement research in physical therapy. Researchers and clinicians need a common vocabulary and language for thinking and speaking about the process of disablement, although it appears premature to reach consensus on any one conceptual approach. Physical therapists should play an active role in guiding future research and scholarship on physical disablement.

Mesh:

Year:  1994        PMID: 8171099     DOI: 10.1093/ptj/74.5.380

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  19 in total

1.  Clinical specificity and the non-generalities of science. On innovation strategies for neurological physical therapy.

Authors:  A Lettinga; A Mol
Journal:  Theor Med Bioeth       Date:  1999-12

2.  The assessment of function: How is it measured? A clinical perspective.

Authors:  Michael P Reiman; Robert C Manske
Journal:  J Man Manip Ther       Date:  2011-05

3.  Relationships among age, body weight, resting heart rate, and performance in a new test of lift capacity.

Authors:  L N Matheson
Journal:  J Occup Rehabil       Date:  1996-12

4.  Questionnaire to evaluate the effects of assistive devices and altered working methods in women with rheumatoid arthritis.

Authors:  U Nordenskiöld; G Grimby; S Dahlin-Ivanoff
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

5.  Characteristics associated with fear of falling and activity restriction in community-living older persons.

Authors:  Susan L Murphy; Christianna S Williams; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2002-03       Impact factor: 5.562

6.  Using disablement models and clinical outcomes assessment to enable evidence-based athletic training practice, part I: disablement models.

Authors:  Alison R Snyder; John T Parsons; Tamara C Valovich McLeod; R Curtis Bay; Lori A Michener; Eric L Sauers
Journal:  J Athl Train       Date:  2008 Jul-Aug       Impact factor: 2.860

Review 7.  Patient-Reported Measures of Physical Function in Knee Osteoarthritis.

Authors:  Daniel K White; Hiral Master
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

8.  A unique patient population? Health-related quality of life in adolescent athletes versus general, healthy adolescent individuals.

Authors:  Kenneth C Lam; Alison R Snyder Valier; R Curtis Bay; Tamara C Valovich McLeod
Journal:  J Athl Train       Date:  2013-02-20       Impact factor: 2.860

9.  Association of the veterans aging cohort study index with exercise capacity in HIV-infected adults.

Authors:  Krisann K Oursler; Janet P Tate; Thomas M Gill; Kristina Crothers; Todd T Brown; Stephen Crystal; Julie Womack; David A Leaf; John D Sorkin; Amy C Justice
Journal:  AIDS Res Hum Retroviruses       Date:  2013-06-26       Impact factor: 2.205

10.  The development of fear of falling among community-living older women: predisposing factors and subsequent fall events.

Authors:  Susan L Murphy; Joel A Dubin; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-10       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.